Mometasone Zentiva (Mometasone Furoate Monohydrate)

Mometasone furoate monohydrate, the active ingredient in Mometasone Zentiva, is a corticosteroid presented as a nasal spray for intranasal use. It reduces nasal inflammation and is indicated for allergic rhinitis and other nasal inflammatory conditions.

GNH USA supplies Mometasone Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a nasal corticosteroid that acts on the inflammatory pathway of the nasal mucosa. - Allergic rhinitis: provides relief of nasal congestion, itching, sneezing and rhinorrhoea. - Nasal polyposis (post‑surgical): helps prevent recurrence of polyps after sinus surgery. - Non‑allergic rhinitis: reduces nasal inflammation and improves airflow.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleed). - Throat irritation or cough. - Altered taste or oral dryness.

Serious or Rare Side Effects: - Adrenal suppression with prolonged high‑dose use. - Fungal infection of the nasal passages. - Severe allergic reaction (anaphylaxis). - Vision changes or ocular pressure increase. - Nasal septum perforation.

Before using Mometasone Zentiva, consider the following precautions. - Pregnancy: consult a healthcare professional before initiating therapy. - Breastfeeding: discuss potential risks with a physician. - Active nasal infection: avoid use until the infection is resolved. - Upcoming nasal or sinus surgery: discontinue the spray as advised by the surgeon. - Long‑term therapy: monitor for signs of adrenal suppression. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Mometasone furoate may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug exposure. - Live vaccines: nasal corticosteroid may diminish vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal nasal sprays: may increase local irritation. - Antihistamines: additive sedative effect is unlikely but monitor symptoms. - Immunosuppressants: watch for heightened infection risk.